CN2517411Y - Implanting tear duct probe for artificial tear duct - Google Patents

Implanting tear duct probe for artificial tear duct Download PDF

Info

Publication number
CN2517411Y
CN2517411Y CN 01257557 CN01257557U CN2517411Y CN 2517411 Y CN2517411 Y CN 2517411Y CN 01257557 CN01257557 CN 01257557 CN 01257557 U CN01257557 U CN 01257557U CN 2517411 Y CN2517411 Y CN 2517411Y
Authority
CN
China
Prior art keywords
needle body
tear duct
tear
artificial tear
guide line
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 01257557
Other languages
Chinese (zh)
Inventor
肖满意
戴珊珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Xiangya Hospital of Central South University
Original Assignee
Second Xiangya Hospital of Central South University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Xiangya Hospital of Central South University filed Critical Second Xiangya Hospital of Central South University
Priority to CN 01257557 priority Critical patent/CN2517411Y/en
Application granted granted Critical
Publication of CN2517411Y publication Critical patent/CN2517411Y/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Prostheses (AREA)

Abstract

The utility model relates to an artificial probe for implanting the tear tube into the tear channel, comprising an injector connecting part and a combining needle body, which is characterized in that a narrow void is arranged on the hollow tube wall of the needle body along the axial direction of the needle body; a tear point expanding device is arranged at the end of the needle body. An oriented mark indicating the position of the narrow void is made at the connecting part of the injector; the tear point expanding device is smoothly connected by a transitional cone and an end sphere. A wire inlet hole with bigger diameter is arranged in the narrow void at an end of the connecting part of the adjacent injector, a wire outlet hole with bigger diameter is arranged in the narrow void at an end of the adjacent tear point expanding device. The needle body is made of stainless steel harder than medium. The artificial probe for implanting the tear tube into the tear channel of the utility model is suitable for the operation of implanting double-tube artificial tear tube, the line and the needle can be isolated easily, the operation can be simplified, the pain of the patients can be reduced, and the utility model has a simple structure, low cost and easy popularization.

Description

Artificial tear duct is implanted lacrimal probe
Technical field: this utility model relates to medical science ophthalmic diseases operating theater instruments, relates in particular to the improvement of lacrimal probe structure.
Background technology: lacrimal duct abstruction is common lacrimal passage disease, the existing clinically method of taking two-tube artificial tear duct to implant and undergo surgery and treat, and when carrying out above-mentioned operative treatment, guide line and artificial tear duct need be inserted inferior nasal meatus earlier through lacrimal ductule, manage again to take out from nasal cavity.And original lacrimal probe can only be sent into seal wire inferior nasal meatus, and the nasal cavity that seal wire can not be led, so be difficult to from nasal cavity, draw seal wire, and for the spool integrative-structure the double hose artificial tear duct, because of can not making the line pin after the artificial tear duct implantation puts in place, it separates to extract needle body out, so can not adapt to traction, the implantation of double hose artificial tear duct fully, make troubles to operation technique, increased patient's misery.
Summary of the invention: technical problem to be solved in the utility model is: a kind of two-tube artificial tear duct implant surgery that is applicable to is provided, can easily carry out line, the isolating special-purpose artificial tear duct implantation lacrimal probe of pin.
For this reason, the technical solution of the utility model is: a kind of artificial tear duct is implanted lacrimal probe,, be it is characterized in that in conjunction with forming by syringe connecting portion, needle body: along described needle body axially, on the hollow tube wall of needle body, have a narrow crack together.
On described syringe connecting portion, also indicate the leading mark in indication orientation, narrow crack; Be provided with the punctum dilator that constitutes with terminal smooth connection of hemisphere by transition-cone in the bottom of needle body.
Have the guide line hand-hole of a slightly larger in diameter in the narrow crack of an end of contiguous described syringe connecting portion, the guide line that has a slightly larger in diameter in the narrow crack of an end of contiguous described punctum dilator portals.
The internal diameter of described needle body is 0.33~0.66mm, actual value 0.50mm; External diameter is 0.60~1.20mm, actual value 1.00mm; Length is 40~100mm, actual value 80mm; Described narrow gap length is 0.3mm; Described guide line hand-hole is at the following 2mm of syringe connecting portion, and described guide line portals at the above 1mm of punctum dilator; Described transition-cone height is 3mm, and terminal hemisphere diameter is 0.3mm.
Described needle body is that the hard medical stainless steel material of isogonic is made in using.
Owing to adopted the structure after the above improvement, clinically, allow the doctor that the punctum dilator and the probe of round end are probeed into nasal cavity, and whole process leads the guiding lead and submissively derives automatically from nasal cavity, and cause wound can not for patient's lacrimal passage and nasal cavity interior tissue, when lead lead put in place after, can easily this implantable probe be separated with guide line again, from lacrimal ductule and nasal meatus, extract out again, thereby make things convenient for doctor's operation technique, and alleviate patient's misery and complication; This utility model is simple in structure, and is with low cost, is easy to promote.
Description of drawings: the utility model is described in further detail below in conjunction with accompanying drawing.
Fig. 1 is the positive view of this utility model embodiment.
Fig. 2 is that the A of Fig. 1 is to view.
The specific embodiment: as shown in Figure 1, 2, a kind of artificial tear duct is implanted lacrimal probe,, be it is characterized in that in conjunction with forming by syringe connecting portion 1, needle body 2: along described needle body 2 axially, on the hollow tube wall of needle body 2, have narrow crack 3 one.
On described syringe connecting portion 1, also indicate the leading mark 5 in indication orientation, narrow crack; Be provided with the punctum dilator that constitutes with terminal smooth connection of hemisphere 4-2 by transition-cone 4-1 in the bottom of needle body.
In the narrow crack of an end of contiguous described syringe connecting portion 1, have the guide line hand-hole 3-1 of a slightly larger in diameter, the guide line that in the narrow crack of transition-cone 4-1 one end of contiguous described punctum dilator, has the slightly larger in diameter 3-2 that portals.
The internal diameter of described needle body 2 is 0.50mm, and external diameter is 1.00mm, and length is 80mm; Described narrow crack 3 is wide to be 0.3mm; Described guide line hand-hole 3-1 is at syringe connecting portion 1 following 2mm, and described guide line portals 3-2 at the above 1mm of the transition-cone 4-1 of punctum dilator; Described transition-cone 4-1 highly is 3mm, and terminal hemisphere 4-2 diameter is 0.3mm.
Described needle body 2 is that the hard medical stainless steel material of isogonic is made in using.
Now in conjunction with its operational approach of above description of drawings: implant the lacrimal ductule that lacrimal probe needle body 2 is visited logical patient successively with artificial tear duct of the present utility model earlier, the tear house steward, lachrymal sac, nasolacrimal duct, and enter nasal cavity, needle body 2 is kept somewhere in the lacrimal passage, then the guide line hand-hole 3-1 of the guide line on the artificial tear duct on needle body pushed the inwall of needle body 2 and along skidding off voluntarily through the guide line 3-2 that portals in the narrow crack 3 downwards, make guide line from nasal cavity, derive automatically, then guide line can be pulled out from the narrow crack 3 of probe needle body 2 and make line, pin separates, again needle body 2 and whole probe are extracted out from nasal cavity, utilize the guide line traction artificial tear duct of staying outside the nasal cavity to put in place then, finish the artificial tear duct implant surgery.

Claims (5)

1, a kind of artificial tear duct is implanted lacrimal probe,, be it is characterized in that in conjunction with forming by syringe connecting portion, needle body: along described needle body axially, on the hollow tube wall of needle body, have a narrow crack together.
2, artificial tear duct as claimed in claim 1 is implanted lacrimal probe, it is characterized in that: the leading mark that also indicates indication orientation, narrow crack on described syringe connecting portion; Be provided with the punctum dilator that constitutes with terminal smooth connection of hemisphere by transition-cone in the bottom of needle body.
3, artificial tear duct as claimed in claim 1 or 2 is implanted lacrimal probe, it is characterized in that: have the guide line hand-hole of a slightly larger in diameter in the narrow crack of an end of contiguous described syringe connecting portion, the guide line that has a slightly larger in diameter in the narrow crack of an end of contiguous described punctum dilator portals.
4, artificial tear duct as claimed in claim 3 is implanted lacrimal probe, and it is characterized in that: the internal diameter of described needle body is 0.33~0.66mm, actual value 0.50mm; External diameter is 0.60~1.20mm, actual value 1.00mm; Length is 40~100mm, actual value 80mm; Described narrow gap length is 0.3mm; Described guide line hand-hole is at the following 2mm of syringe connecting portion, and described guide line portals at the above 1mm of punctum dilator; Described transition-cone height is 3mm, and terminal hemisphere diameter is 0.3mm.
5, artificial tear duct as claimed in claim 4 is implanted lacrimal probe, it is characterized in that: described needle body is that the hard medical stainless steel material of isogonic is made in using.
CN 01257557 2001-12-18 2001-12-18 Implanting tear duct probe for artificial tear duct Expired - Fee Related CN2517411Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01257557 CN2517411Y (en) 2001-12-18 2001-12-18 Implanting tear duct probe for artificial tear duct

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01257557 CN2517411Y (en) 2001-12-18 2001-12-18 Implanting tear duct probe for artificial tear duct

Publications (1)

Publication Number Publication Date
CN2517411Y true CN2517411Y (en) 2002-10-23

Family

ID=33666279

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01257557 Expired - Fee Related CN2517411Y (en) 2001-12-18 2001-12-18 Implanting tear duct probe for artificial tear duct

Country Status (1)

Country Link
CN (1) CN2517411Y (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101442954B (en) * 2006-05-17 2010-12-08 药物混合系统股份公司 Dispensing device with a spray assembly

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101442954B (en) * 2006-05-17 2010-12-08 药物混合系统股份公司 Dispensing device with a spray assembly

Similar Documents

Publication Publication Date Title
US4658816A (en) Lighted canaliculus intubation sets
CN2517411Y (en) Implanting tear duct probe for artificial tear duct
CN106983596A (en) A kind of Lacrimal passage indwelling tube
CN209004811U (en) A kind of minimally invasive dilating drainage external member of the percutaneous kidney of tearable negative pressure taking stone
CN205459331U (en) Children's tear way pipe
CN215020349U (en) Simple and easy tear duct of improvement type is visited and is put a tub ware
CN104107500A (en) Sterile super-lubricity antiseep safety catheter structure
CN2717415Y (en) Memory type tear duct dilating drainage tube
CN203468802U (en) Lacrimal passage drainage support
CN200948286Y (en) Maxillary antrum indwelling lavement device
CN203244667U (en) Dacryocyst catheter
CN2489748Y (en) Petal-shape artificial lacrimal duct
CN202314625U (en) Human auditory tube washing device
CN101015486A (en) Supporting artificial tube
CN2489745Y (en) Lacrimal probe with structure for directional leading-out guide filiform
CN205215276U (en) Mirror sheath
CN212880579U (en) Indwelling catheter
CN2250160Y (en) Lacrimal duct retrograde implanting tube operation equipment
CN218943686U (en) Lacrimal canaliculus broken end gas injection method searching device
CN219921355U (en) Optical fiber catheter inserted into Schlemm's canal
CN2518483Y (en) Lacrimal implantation tube
CN215459248U (en) Lacrimal passage expansion bracket
CN220141881U (en) Lacrimal passage bypass artificial tube and auxiliary imbedding device
CN2489746Y (en) Cup artificial masolacrimal duct
CN201150595Y (en) Artificial lacrimal duct with aliform fixed ring

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee